HPV Vaccine Adverse Events Reported to VAERS as of November 13, 2012

HPV4 Gardasil & HPV 2 Cervarix – Adverse Reactions and Deaths as reported to the Vaccine Adverse Event Reporting System

Janny Stokvis, HPV Vaccine VAERS  researcher and analyst has compiled that latest adverse events from the HPV vaccines, Gardasil and Cervarix as reported to the Vaccine Adverse Event Reporting System. It is estimated only 1 to 10% of the vaccine injured are reporting. Please note the significant number of girls reporting abnormal pap smears, cervical dysplasia and cervical cancer.  Remember most women do not get cervical cancer until their 50’s or even older.  The reports here are for girls ages 9 to 26 – the market the vaccines were approved for.


In just over two months – almost 1,000 new reports of adverse reactions from the HPV vaccines – Gardasil and Cervarix.

 

August 17, 2012 – Notice that three more deaths have been reported to VAERS in the past 30 days. There have been 236 more adverse events reported since June – 1 more case of cervical cancer, 3 more abnormal pap smears, and 2 more reports of cervical dysplasia.

 

 

Adverse Events Reported To VAERS from HPV 4 Gardasil and HPV 2 Cevarix include – but are not limited to:

 

 

PG

Author: Leslie Carol Botha

Author, publisher, radio talk show host and internationally recognized expert on women's hormone cycles. Social/political activist on Gardasil the HPV vaccine for adolescent girls. Co-author of "Understanding Your Mood, Mind and Hormone Cycle." Honorary advisory board member for the Foundation for the Study of Cycles and member of the Society for Menstrual Cycle Research.
About Leslie Carol Botha

Author, publisher, radio talk show host and internationally recognized expert on women's hormone cycles. Social/political activist on Gardasil the HPV vaccine for adolescent girls. Co-author of "Understanding Your Mood, Mind and Hormone Cycle." Honorary advisory board member for the Foundation for the Study of Cycles and member of the Society for Menstrual Cycle Research.